HighTower Advisors’s Aspen Aerogels ASPN Stock Holding History

HighTower Advisors’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,847	Closed	-$75.5K	–	3673
2025 Q3	$75.5K	Buy	+10,847	New	+$76.5K	﹤0.01%	3581

Other funds holding ASPN

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's ASPN Position: Q4 2025 in Review

HighTower Advisors sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 10,847 shares — an estimated $75.5K sold.

HighTower Advisors first reported a position in ASPN in Q3 2025 and held it in 1 quarter. The position peaked at $75.5K in Q3 2025. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

HighTower Advisors reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
HighTower Advisors sold 10,847 Aspen Aerogels shares in Q4 2025, an estimated $75.5K.
HighTower Advisors first reported a position in Aspen Aerogels in Q3 2025 and held it in 1 quarter.
HighTower Advisors's Aspen Aerogels position peaked at $75.5K in Q3 2025.
183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on HighTower Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.